Biomarin Pharmaceutical (BMRN) EPS (Basic) (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted EPS (Basic) of $0.55 for Q1 2026, up 325.75% on a QoQ basis from -$0.24 in Q4 2025, and down 43.62% year-over-year from $0.97 in Q1 2025.
Biomarin Pharmaceutical (BMRN) EPS (Basic) (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical's EPS (Basic) history runs 18 years deep, the most recent figure standing at $0.55 for Q1 2026.
- Quarterly EPS (Basic) fell 43.62% year-over-year to $0.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 (down 49.11% YoY) and the FY2025 annual result came in at $1.82, down 19.01% from the prior year.
- EPS (Basic) was $0.55 for Q1 2026 at Biomarin Pharmaceutical, up from -$0.24 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.25 in Q2 2025 and bottomed at -$0.24 in Q4 2025.
- A 5-year average of $0.37 and a median of $0.3 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 8170.86% — and 2025, when it plunged 136.93%.
- Biomarin Pharmaceutical's EPS (Basic) stood at -$0.0 in 2022, then jumped by 8170.86% to $0.11 in 2023, then jumped by 506.14% to $0.66 in 2024, then slumped by 136.93% to -$0.24 in 2025, then surged by 325.75% to $0.55 in 2026.
- Business Quant data shows BMRN's EPS (Basic) at $0.55 in Q1 2026, -$0.24 in Q4 2025, and -$0.16 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Biomarin Pharmaceutical | 11.41 Bn | 9.18 Bn | 571.21 Mn | 0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.55 |
| Dec 31, 2025 | -0.24 |
| Sep 30, 2025 | -0.16 |
| Jun 30, 2025 | 1.25 |
| Mar 31, 2025 | 0.97 |
| Dec 31, 2024 | 0.66 |
| Sep 30, 2024 | 0.56 |
| Jun 30, 2024 | 0.56 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.11 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 0.27 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.66 |
| Dec 31, 2021 | -0.32 |
| Sep 30, 2021 | -0.20 |
| Jun 30, 2021 | 0.07 |